Lonza Biologics Plant Expansion, Portsmouth, NH, USA
Key Data:
Order year
2000
Project type
Facility expansion
Location
New Hampshire, USA
Estimated investment
$207m, phase three $300m (€220m)
Completion
August 2004, Phase three mid-2008
Key Players:
Sponsor
Lonza Biologics
Lead contractor
Parsons, US (www.parsons.com)
Subcontractors
Emerson Process Management, US
Kinetics Modular Systems (KMS), US
PROCONEX, US
New England Controls, US
Appledore Engineering
Output chemicals
Therapeutic proteins and monoclonal antibodies
Units/tablets (year)
Phase two quadrupled capacity and now phase three is addressing mid-scale production
